Arbor Pharmaceuticals Recalls Cetylev Tablets Due to Defective Blister Packaging
Arbor Pharmaceuticals is recalling Cetylev (acetylcysteine) effervescent tablets because incomplete seals on the blister packaging allow moisture to enter, causing the tablets to swell.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class I, which mandates a minimum score of 4 per the rubric, despite the defect being a packaging issue without reported injuries.
Plain-English summary
Arbor Pharmaceuticals Inc. is recalling 16,932 cartons of Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg. The affected product is distributed in California, Florida, Georgia, Louisiana, Missouri, Mississippi, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, and West Virginia. The recall involves lot numbers 005C16, 006C16, and 007C16, which have an expiration date of 02/2018.
The recall is being conducted due to a defective container issue. Specifically, the blister packaging has incomplete seals that allow oxygen and moisture to enter. This exposure initiates the effervescence process, leading to the tablets swelling and enlarging. The source text does not report any illnesses or injuries associated with this defect.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or Arbor Pharmaceuticals for further instructions or a refund.
The recalled product
- Product
- Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, Rx Only, 20 tablets per carton (ten 2 count blister packs), Distributed by Arbor Pharmaceuticals, LLC Atlanta, GA 30328, NDC 24338-700-10.
- Manufacturer
- Arbor Pharmaceuticals Inc.
- Category
- Drug — Prescription Medication
- Affected units
- 16,932
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot numbers: 005C16
- 006C16
- 007C16
- Exp 02/2018
Distribution
Related recalls
Same manufacturer · Arbor Pharmaceuticals Inc.
See all →- LowArbor Pharmaceuticals Recalls Subpotent Nymalize Oral Solution
FDA (Drugs) · 2020-10-07
- LowArbor Pharmaceuticals Recalls Testosterone Cypionate Injection Due to Labeling Error
FDA (Drugs) · 2019-11-06
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12